2010
A Randomized Trial Comparing Mail versus In‐Office Distribution of the CAHPS Clinician and Group Survey
Anastario MP, Rodriguez HP, Gallagher PM, Cleary PD, Shaller D, Rogers WH, Bogen K, Safran DG. A Randomized Trial Comparing Mail versus In‐Office Distribution of the CAHPS Clinician and Group Survey. Health Services Research 2010, 45: 1345-1359. PMID: 20579126, PMCID: PMC2965508, DOI: 10.1111/j.1475-6773.2010.01129.x.Peer-Reviewed Original ResearchConceptsPatient care experiencesCare experiencesLower overall response rateOverall response rateComparison of physicianChoice of patientsCAHPS ClinicianResponse ratePractice sitesSurvey scoresAnalytic samplePotential rolePatientsCliniciansDistribution ratePhysiciansFurther testingValid assessmentSurvey distributionNew York StateGroup surveyMailTrialsWeeksRate
2001
Quality of informed consent in cancer clinical trials: a cross-sectional survey
Joffe S, Cook E, Cleary P, Clark J, Weeks J. Quality of informed consent in cancer clinical trials: a cross-sectional survey. The Lancet 2001, 358: 1772-1777. PMID: 11734235, DOI: 10.1016/s0140-6736(01)06805-2.Peer-Reviewed Original ResearchConceptsClinical trialsCancer clinical trialsFuture patientsConsent formCross-sectional surveyNon-standard treatmentAdult patientsInformed consent processTrial participantsIncremental riskProviders' beliefsMultivariate analysisPatientsUncertainty of benefitPatient consentClinical researchStandard questionnaireInformed consentTrialsConsent processTherapeutic misconceptionCancer therapyConsentParticipantsTreatment
1995
Health-related quality of life in patients with advanced prostate cancer: A multinational perspective
Cleary P, Morrissey G, Oster G. Health-related quality of life in patients with advanced prostate cancer: A multinational perspective. Quality Of Life Research 1995, 4: 207-220. PMID: 7613531, DOI: 10.1007/bf02260860.Peer-Reviewed Original ResearchConceptsHealth-related qualityAdvanced prostate cancerProstate cancerSelf-administered patient questionnaireUntreated metastatic prostate cancerObjective tumor responseDomains of HRQOLMetastatic prostate cancerAntiandrogen therapyPatient questionnaireStudy entryTreatment failureStudy treatmentTumor responseClinical trialsPatientsCancerTrialsTreatmentQuestionnaireHRQoLAntiandrogensTherapyCastrationFocus of concern
1994
Functional disability screening of ambulatory patients
Calkins D, Rubenstein L, Cleary P, Davies A, Jette A, Fink A, Kosecoff J, Young R, Brook R, Delbanco T. Functional disability screening of ambulatory patients. Journal Of General Internal Medicine 1994, 9: 590-592. PMID: 7823232, DOI: 10.1007/bf02599291.Peer-Reviewed Original ResearchConceptsControl group physiciansGroup physiciansFunctional disabilityInternal medicine group practiceExperimental group physiciansSelf-administered questionnaireAmbulatory patientsPatient functionFunctional statusPatient responseDisability screeningControl groupPatientsPhysiciansGroup practiceSignificant differencesDisabilityReportGroupSocial functionTrialsMonthsResponse
1991
Health-Related Quality of Life Among Patients Undergoing Percutaneous Transluminal Coronary Angioplasty
Cleary P, Epstein A, Oster G, Morrissey G, Stason W, Debussey S, Plachetka J, Zimmerman M. Health-Related Quality of Life Among Patients Undergoing Percutaneous Transluminal Coronary Angioplasty. Medical Care 1991, 29: 939-950. PMID: 1921527, DOI: 10.1097/00005650-199110000-00001.Peer-Reviewed Original ResearchMeSH KeywordsActivities of Daily LivingAdultAgedAngioplasty, Balloon, CoronaryBiphenyl CompoundsCoronary DiseaseEvaluation Studies as TopicHealth Status IndicatorsHeptanoic AcidsHumansInterviews as TopicMiddle AgedOutcome Assessment, Health CarePsychometricsQuality of LifeRandomized Controlled Trials as TopicSurveys and QuestionnairesTelephoneUnited StatesConceptsPercutaneous transluminal coronary artery angioplastyPercutaneous transluminal coronary angioplastyCoronary artery angioplastyHealth-related qualityTransluminal coronary angioplastyNew antiplatelet agentsRandomized clinical trialsQuality of lifeArtery angioplastyAntiplatelet agentsCoronary angioplastyPatient questionnaireStudy entryPatient populationSeparate clinical sitesClinical trialsPatientsClinical sitesSexual functioningTelephone administrationHome managementPhysical wellAngioplastyPsychometric propertiesTrials